127 related articles for article (PubMed ID: 6456025)
1. In vitro cell growth in neonates with Down's syndrome and transient myeloproliferative disorder.
Denegri JF; Rogers PC; Chan KW; Sadoway J; Thomas JW
Blood; 1981 Oct; 58(4):675-7. PubMed ID: 6456025
[TBL] [Abstract][Full Text] [Related]
2. Infants with Down's syndrome. Use of cytogenetic studies and in vitro colony assay for granulocyte progenitor to distinguish acute nonlymphocytic leukemia from a transient myeloproliferative disorder.
de Alarcon PA; Patil S; Golberg J; Allen JB; Shaw S
Cancer; 1987 Sep; 60(5):987-93. PubMed ID: 2955884
[TBL] [Abstract][Full Text] [Related]
3. Differentiation of blast cells from a Down's syndrome patient with transient myeloproliferative disorder.
Suda J; Eguchi M; Akiyama Y; Iwama Y; Furukawa T; Sato Y; Miura Y; Suda T; Saito M
Blood; 1987 Feb; 69(2):508-12. PubMed ID: 2948580
[TBL] [Abstract][Full Text] [Related]
4. Neonate with Down's syndrome and transient congenital leukemia. In vitro studies.
Rogers PC; Kalousek DK; Denegri JF; Thomas JW; Baker MA
Am J Pediatr Hematol Oncol; 1983; 5(1):59-64. PubMed ID: 6222664
[TBL] [Abstract][Full Text] [Related]
5. Transient myeloproliferative disorder in chromosomally normal newborn infant.
Kalousek DK; Chan KW
Med Pediatr Oncol; 1987; 15(1):38-41. PubMed ID: 2951583
[TBL] [Abstract][Full Text] [Related]
6. Characterization of the blast cell population in two neonates with Down's syndrome and transient myeloproliferative disorder.
Coulombel L; Derycke M; Villeval JL; Leonard C; Breton-Gorius J; Vial M; Bourgeois P; Tchernia G
Br J Haematol; 1987 May; 66(1):69-76. PubMed ID: 2954579
[TBL] [Abstract][Full Text] [Related]
7. "Leukemic" pattern of in vitro growth in a patient with Down syndrome and transient myeloproliferative disorder.
Mendelow B; Krawitz S; Cohn R; Bernstein R
Am J Hematol; 1984 Apr; 16(3):293-6. PubMed ID: 6231857
[TBL] [Abstract][Full Text] [Related]
8. Platelet peroxidase-positive blast cells in transient myeloproliferative disorder with Down's syndrome.
Suda J; Eguchi M; Ozawa T; Furukawa T; Hayashi Y; Kojima S; Maeda H; Tadokoro K; Sato Y; Miura Y
Br J Haematol; 1988 Feb; 68(2):181-7. PubMed ID: 2964860
[TBL] [Abstract][Full Text] [Related]
9. Neonatal myeloproliferative disorders in Down's syndrome and congenital leukemias.
Paolucci G; Rosito P
Haematologica; 1987; 72(6 Suppl):121-5. PubMed ID: 2965083
[No Abstract] [Full Text] [Related]
10. Cytogenetic findings and clinical features in acute leukemia and transient myeloproliferative disorder in Down's syndrome.
Hayashi Y; Eguchi M; Sugita K; Nakazawa S; Sato T; Kojima S; Bessho F; Konishi S; Inaba T; Hanada R
Blood; 1988 Jul; 72(1):15-23. PubMed ID: 2968822
[TBL] [Abstract][Full Text] [Related]
11. Leukemia with Down's syndrome: translocation between chromosomes 1 and 19 in acute myelomonocytic leukemia following transient congenital myeloproliferative syndrome.
Morgan R; Hecht F; Cleary ML; Sklar J; Link MP
Blood; 1985 Dec; 66(6):1466-8. PubMed ID: 2415189
[TBL] [Abstract][Full Text] [Related]
12. Test and teach. Number Seventy. Diagnosis: Transient myeloproliferative disorder in a child with Down's syndrome.
Wright SJ; Kerwick AM; Rodwell RL; Taylor KM
Pathology; 1993 Apr; 25(2):133, 207-8. PubMed ID: 8367191
[No Abstract] [Full Text] [Related]
13. Ultrastructural and ultracytochemical differences between transient myeloproliferative disorder and megakaryoblastic leukaemia in Down's syndrome.
Eguchi M; Sakaibara H; Suda J; Ozawa T; Hayashi Y; Sato T; Kojima S; Furukawa T
Br J Haematol; 1989 Nov; 73(3):315-22. PubMed ID: 2532535
[TBL] [Abstract][Full Text] [Related]
14. Prenatal diagnosis of transient myeloproliferative disorder via percutaneous umbilical blood sampling. Report of two cases in fetuses affected by Down's syndrome.
Foucar K; Friedman K; Llewellyn A; McConnell T; Aisenbrey G; Argubright K; Ballinger L
Am J Clin Pathol; 1992 Apr; 97(4):584-90. PubMed ID: 1532471
[TBL] [Abstract][Full Text] [Related]
15. Down's syndrome with transient myeloproliferative disorder.
Dhaded SM; Das R; Kumar P; Narang A
Indian Pediatr; 1996 Nov; 33(11):964-6. PubMed ID: 9141835
[No Abstract] [Full Text] [Related]
16. Natural killer cell activity and ultrastructure in myeloproliferative reactions in infants with Down's syndrome.
Miale TD; Nasrallah AG; Lobel SA; Demian S; Bowman WP
Am J Pediatr Hematol Oncol; 1986; 8(3):191-9. PubMed ID: 2945495
[TBL] [Abstract][Full Text] [Related]
17. Clonal analysis of transient myeloproliferative disorder in Down's syndrome.
Miyashita T; Asada M; Fujimoto J; Inaba T; Takihara Y; Sugita K; Bessho F; Furukawa T; Mizutani S
Leukemia; 1991 Jan; 5(1):56-9. PubMed ID: 1825681
[TBL] [Abstract][Full Text] [Related]
18. Hematological changes in Down's syndrome.
Ganick DJ
Crit Rev Oncol Hematol; 1986; 6(1):55-69. PubMed ID: 2946491
[TBL] [Abstract][Full Text] [Related]
19. Transient myeloproliferative disorder and acute myeloid leukemia: study of six neonatal cases with long-term follow-up.
Liang DC; Ma SW; Lu TH; Lin ST
Leukemia; 1993 Oct; 7(10):1521-4. PubMed ID: 8412314
[TBL] [Abstract][Full Text] [Related]
20. Transient myeloproliferative disorder in Down's syndrome.
Kshirsagar VY; Ahmed M; Colaco SM; Ahmed M
Indian J Pathol Microbiol; 2012; 55(3):426-7. PubMed ID: 23032858
[No Abstract] [Full Text] [Related]
[Next] [New Search]
